OMENN GILBERT S — SEC insider filings

SEC reporting owner CIK 1184227. 38 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2020-09-29 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Amesite Inc. (AMST)Director284 legs · 39,333 sh · $128,824—32
Angion Biomedica Corp. (ANGN)Director3——8
GALECTIN THERAPEUTICS INC (GALT)Director7——8

Insider filings — OMENN GILBERT S

FiledFormIssuerReported transactionsSource
2026-10-024Amesite Inc. (AMST)Grant/award (A): 12,121 (derivative) @ $0EDGAR
2026-07-014Amesite Inc. (AMST)Grant/award (A): 9,023 (derivative) @ $0EDGAR
2026-04-014Amesite Inc. (AMST)Grant/award (A): 6,522 (derivative) @ $0EDGAR
2026-03-104Amesite Inc. (AMST)Option exercise (M): 41,322 · Option exercise (M): 41,322 (derivative) @ $0EDGAR
2026-02-104Amesite Inc. (AMST)Grant/award (A): 49,751 (derivative) @ $0EDGAR
2026-01-214GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2026-01-054Amesite Inc. (AMST)Grant/award (A): 6,349 (derivative) @ $0EDGAR
2025-10-024Amesite Inc. (AMST)Grant/award (A): 3,934 (derivative) @ $0EDGAR
2025-07-024Amesite Inc. (AMST)Grant/award (A): 4,461 (derivative) @ $0EDGAR
2025-04-024Amesite Inc. (AMST)Grant/award (A): 4,959 (derivative) @ $0EDGAR
2025-03-114Amesite Inc. (AMST)Option exercise (M): 14,620 · Grant/award (A): 41,322 · Option exercise (M): 14,620 (derivative) @ $0 · Grant/award (A): 41,322 (derivative) @ $0EDGAR
2025-01-274GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-01-274GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-01-164Amesite Inc. (AMST)Option exercise (M): 36,630 · Option exercise (M): 36,630 (derivative) @ $0EDGAR
2025-01-084Amesite Inc. (AMST)Purchase (P): 3,333 @ $3EDGAR
2025-01-034Amesite Inc. (AMST)Grant/award (A): 2,526 (derivative) @ $0EDGAR
2024-10-024Amesite Inc. (AMST)Grant/award (A): 4,898 (derivative) @ $0EDGAR
2024-07-024Amesite Inc. (AMST)Grant/award (A): 4,000 (derivative) @ $0EDGAR
2024-04-014Amesite Inc. (AMST)Grant/award (A): 5,381 (derivative) @ $0EDGAR
2024-02-074GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 50,000 (derivative) @ $0EDGAR
2024-01-184Amesite Inc. (AMST)Grant/award (A): 36,630 (derivative) @ $0EDGAR
2024-01-034Amesite Inc. (AMST)Grant/award (A): 5,333 (derivative) @ $0EDGAR
2023-10-034Amesite Inc. (AMST)Grant/award (A): 4,706 (derivative) @ $0EDGAR
2023-07-054Amesite Inc. (AMST)Grant/award (A): 3,324 (derivative) @ $0EDGAR
2023-04-044Amesite Inc. (AMST)Grant/award (A): 4,598 (derivative) @ $0EDGAR
2023-01-304GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-01-054Amesite Inc. (AMST)Grant/award (A): 68,571 (derivative) @ $0EDGAR
2022-10-034Amesite Inc. (AMST)Grant/award (A): 49,793 (derivative) @ $0EDGAR
2022-07-054/AAmesite Inc. (AMST)Grant/award (A): 21,053 (derivative) @ $0EDGAR
2022-07-054Amesite Inc. (AMST)Grant/award (A): 26,087 (derivative) @ $0EDGAR
2022-06-134Angion Biomedica Corp. (ANGN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-04-044Amesite Inc. (AMST)Grant/award (A): 9,184 (derivative) @ $0 · Grant/award (A): 175,439 (derivative) @ $0 · Grant/award (A): 84,211 (derivative) @ $0EDGAR
2022-01-254GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2021-12-154Amesite Inc. (AMST)Purchase (P): 8,000 @ $1.18 · Purchase (P): 8,000 @ $1.17EDGAR
2021-03-294GALECTIN THERAPEUTICS INC (GALT)Grant/award (A): 40,000 (derivative) @ $0 · Grant/award (A): 70,000 (derivative) @ $0EDGAR
2021-03-104Angion Biomedica Corp. (ANGN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-02-114Angion Biomedica Corp. (ANGN)Conversion (C): 23,483 @ $11.57 · Conversion (C): 23,391 @ $11.57 · Conversion (C): 14,783 @ $11.57 · Conversion (C) @ $0 · Conversion (C) @ $0 · Conversion (C) @ $0EDGAR
2020-09-294Amesite Inc. (AMST)Purchase (P): 20,000 @ $5EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184227 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs